Remove 2015 Remove Doctors Remove Physicians
article thumbnail

Um, about that diabetes drug that helped patients lose weight

World of DTC Marketing

Yet the media has led with “diabetes drug leads to major weight loss” Will doctors inform patients? But, will physicians tell patients that results depend on lifestyle intervention and a low-calorie diet? The drug carries a potential risk for a type of thyroid tumor and has a boxed warning.

article thumbnail

Value-Based healthcare won’t work

World of DTC Marketing

SUMMARY: Value-based healthcare is a healthcare delivery model in which providers, including hospitals and physicians, are paid based on patient health outcomes. 90 million people — have difficulty understanding what their doctor tells them about why they are sick and how to take the medications they are given.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Developing new treatment regimens for HIV

European Pharmaceutical Review

In fact, a study published in 2023 in The Lancet HIV revealed that women and men with HIV at age 40 had an average of 39 and 37 years of life left, respectively – only a few years less than that of the general population – if they started antiretroviral therapy (ART) after 2015. World Health Organization. The Global Health Observatory.

article thumbnail

5 Core Tenets of HCP-focused Point-of-Care Marketing

PM360

The EHR is the Holy Grail of POC Messaging (At Least for Now) Reaching HCPs while they’re prescribing is the epitome of physician messaging. These digital wallboards had a smaller footprint within the doctors’ offices, but delivered the messages with much more dynamic effect.

article thumbnail

Comparison of Humira biosimilars in the US and Europe

Pharmaceutical Technology

Until 2010, no regulatory approval pathway for biosimilars existed in the US and the first biosimilar was only approved in the US in 2015. Patients may be reluctant to switch to biosimilars and doctors may have limited incentives to choose biosimilars. Further, there remains scepticism on the efficacy and safety of biosimilars.

article thumbnail

A history of blood cancer treatment

pharmaphorum

Thanks to the dedicated efforts of doctors, patients, carers, and healthcare professionals, people diagnosed with blood cancer are now living longer, with a steady stream of more effective treatments entering the market each year. However, myelodysplastic syndromes and myeloproliferative neoplasms are also prominent types of blood cancer.

article thumbnail

AI-Powered Pain Relief: Interview with Claire Smith, VP at Nevro

Medgadget

HFX was FDA approved in May 2015 for the treatment of chronic back and leg pain, including claims of superiority over traditional SCS treatment. Claire Smith: Currently, if a patient needs their SCS settings changed, they physically go into their physician’s office to have their device manually adjusted. Why is this suboptimal?